Effects of myelopeptides on immune response and morphometrical manifestations of inflammation in experimental penetrating wound of the eye
Myelopid and MP-1 myelopeptide increase the count of antibody-producing cells, reduced under the effect of injury and standard therapy, and do not modify the suppression of delayed hypersensitivity. Injections of myelopid and MP-3 together with standard drugs optimized the traumatic inflammation processes.
Key Wordsmyelopeptides myelopid penetrating wound of the eye
Unable to display preview. Download preview PDF.
- 1.G. G. Avtandilov, Fundamentals of Quantitative Pathology [in Russian], Moscow (2002).Google Scholar
- 2.L. T. Arkhipova, Sympathetic Ophthalmia [in Russian], Moscow (2006).Google Scholar
- 3.V. P. Borovikov, Statistica. The Art of Computer Processing of Data: For Professionals [in Russian], St. Petersburg (2003).Google Scholar
- 4.T. V. Gavrilova and S. V. Gein, Immunomodulating Effects of Myelopeptides in Experimental Penetrating Wounds of the Eyes [in Russian], Ekaterinburg (2004).Google Scholar
- 5.R. V. Petrov, A. A. Mikhailova, and L. A. Fonina, Myelopeptides [in Russian], Moscow (2000).Google Scholar
- 6.M. V. Chereshneva, T. V. Gavrilova, Yu. I. Shilov, et al., Immunopatol., Allergol., Infektol., No. 2, 38–47 (2002).Google Scholar
- 7.M. V. Chereshneva, J. I. Shilov, V. A. Chereshnev, et al., Immunocorrection in Combined Therapy of Patients with Inflammatory Diseases of the Cornea and Vascular Membranes of the Eye [in Russian], Ekaterinburg (2004).Google Scholar
- 9.J. I. Shilov, S. V. Gein, and V. A. Chereshnev, Rus. J. Immunol., 6, No. 3, 301–308 (2001).Google Scholar